Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
DeliriumPostoperative Cognitive Dysfunction
Interventions
DRUG

Rivastigmine Patch

Rivastigmine Patch 4.6 mg/24 hours: 5 cm2 size containing 9 mg rivastigmine applied to upper back preoperatively for a period of 24 hours

OTHER

Placebo Patch

A 2x2 gauze and a Tegaderm dressing applied to upper back within 3 hours of surgery for a period of 24 hours.

Trial Locations (1)

10016

NYU Langone Medical Center, Department of Anesthesiology 550 First Avenue, RR-603, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

NYU Langone Health

OTHER